Alexandria Real Estate Equities

Alexandria Real Estate Equities Inc. is a equity in the USA market. The price is 76.76 USD currently with a change of 0.75 USD (0.01%) from the previous close.

The latest open price was 75.94 USD and the intraday volume is 503,771. The intraday high is 76.98 USD and the intraday low is 75.65 USD. The latest trade time is Monday, August 4, 10:54:49 PDT.

Company Overview

Alexandria Real Estate Equities, Inc. (ARE) is a leading real estate investment trust (REIT) specializing in the development, ownership, and operation of collaborative life science, agtech, and technology campuses.

Founded in 1994 and headquartered in Pasadena, California, Alexandria has established a significant presence in key innovation hubs across North America including:

• Greater Boston
• San Francisco Bay Area
• San Diego
• Seattle
• Maryland
• Research Triangle
• New York City

Portfolio and Market Capitalization

As of March 31, 2024, Alexandria's portfolio encompasses approximately 74.1 million square feet, comprising 42.2 million rentable square feet (RSF) of operating properties and 5.3 million RSF of Class A/A+ properties under construction.

The company's market capitalization stands at $34.4 billion, reflecting its robust position in the real estate sector.

Strategic Focus

Alexandria focuses on creating dynamic and collaborative environments that foster innovation and productivity among its tenants. By clustering high-quality properties within life science mega campuses, the company enhances tenants’ ability to recruit and retain top talent, driving success in the competitive life science and technology sectors.

Venture Capital Platform

In addition to real estate, Alexandria provides strategic capital to transformative life science companies through its venture capital platform, Alexandria Venture Investments. This initiative underscores the company's commitment to supporting innovation and growth within the life science industry.

Financial Performance and Tenants

Financially, Alexandria has demonstrated strong performance, with a total revenue of approximately $3.116 billion in 2024.

The company's diversified tenant base includes prominent organizations such as Eli Lilly and Company, Moderna, Bristol-Myers Squibb, Takeda Pharmaceutical Company, and Roche, contributing to stable cash flows and long-term asset value.

Stock Information

As of August 4, 2025, Alexandria's stock is trading at $76.76 per share, reflecting a 0.99% increase from the previous close.

The company's stock performance and market capitalization underscore its strong position in the real estate investment sector.

Location

• Boston, MA, USA

In summary, Alexandria Real Estate Equities, Inc. stands as a premier REIT dedicated to developing and managing collaborative life science and technology campuses. Through its strategic focus on innovation hubs and support for transformative companies, Alexandria continues to make a positive and lasting impact on the world.